NCT04738188

Efficacy and Safety of TACE on Downstaging Hepatocellular Carcinoma Beyond UCSF Criteria;

Efficacy and Safety of TACE on Downstaging Hepatocellular Carcinoma Beyond UCSF Criteria: a Multi-center, Randomized, Parallel-controlled Study

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 226 (estimated)
• Sponsor: Beijing Tsinghua Chang Gung Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

This is a multicenter, randomized, parallel controlled study to determine the efficacy and safety of transcatheter arterial chemoembolization (TACE) on downstaging hepatocellular carcinoma beyond University of California, San Francisco (UCSF) criteria.

Conditions

• Hepatocellular Carcinoma

Interventions

Type	Name	Description
PROCEDURE	DEB-TACE	Drug-eluting beads transcatheter arterial chemoembolization
PROCEDURE	cTACE	Transcatheter arterial chemoembolization
DEVICE	Drug-eluting Beads	Drug-eluting beads
DRUG	Epirubicin	Chemotherapy drug for intra-arterial infusion

Timeline

• Start date: 2020-03-18
• Primary completion: 2022-11-01
• Completion: 2025-12-01
• First posted: 2021-02-04
• Last updated: 2021-02-04

Locations

1 site across 1 country: China